Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 4,432,860 |
|
|||||
| News | - | ||||||
| Day High | 0.144 | Low High |
|||||
| Day Low | 0.139 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Zomedica Corp | ZOM | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0018 | 1.27% | 0.1434 | 18:49:25 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1424 | 0.139 | 0.144 | 0.142 | 0.1416 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,180 | 4,432,860 | US$ 0.1417634 | US$ 628,417 | - | 0.12 - 0.245 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 1,594 | US$ 0.142 | USD |
Zomedica Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 132.99M | 949.95M | - | 25.19M | -34.53M | -0.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Zomedica News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/29/2024 | 10:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/20/2024 | 05:12 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 11/13/2023 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 15:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/09/2023 | 15:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/09/2023 | 15:06 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 9/21/2023 | 08:35 | GlobeNewswire Inc. | Dawson James Securities Announces October Date for 8th.. |
| 9/06/2023 | 07:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/10/2023 | 15:22 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/10/2023 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZOM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.129 | 0.15 | 0.129 | 0.1396903 | 4,510,284 | 0.0144 | 11.16% |
| 1 Month | 0.1464 | 0.15 | 0.1223 | 0.1362102 | 3,806,352 | -0.003 | -2.05% |
| 3 Months | 0.1271 | 0.1599 | 0.12 | 0.1356683 | 4,826,547 | 0.0163 | 12.82% |
| 6 Months | 0.1705 | 0.2285 | 0.12 | 0.1551367 | 4,947,850 | -0.0271 | -15.89% |
| 1 Year | 0.20 | 0.245 | 0.12 | 0.1720411 | 4,310,782 | -0.0566 | -28.30% |
| 3 Years | 1.04 | 1.07 | 0.12 | 0.4312921 | 12,824,080 | -0.8966 | -86.21% |
| 5 Years | 0.384 | 2.91 | 0.0628 | 0.7158889 | 25,261,367 | -0.2406 | -62.66% |
Zomedica Description
| Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment. |
